RecruitingNCT04623424
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
Intestinal Microbiota Alteration by Antibiotics Used During Stem Cell Transplant Admission
Sponsor
Henry Ford Health System
Enrollment
255 participants
Start Date
Nov 3, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
In this prospective study, the primary objective will be to investigate the association between the use of antibiotics administered during the admission period of Stem cell transplant (SCT) and the rate of overall change in microbiota composition across adjacent samples in time.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria2
- Patients aged 18-80 years
- patients undergoing allogenic or autologous SCT for malignant hematological conditions or bone marrow failure
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTintestinal microbiota
Stoll samples will be tested for different bacteria
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04623424
Related Trials
A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors
NCT065410023 locations
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
NCT0339436571 locations
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
NCT0455491440 locations
Loratadine for the Prevention of G-CSF-related Bone Pain
NCT054214161 location
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
NCT057067662 locations